Research progress of GLAST and nervous system diseases
Author:
Affiliation:

1. Institute of Environmental and Operational Medicine, Academy of Military Medical Sciences, Academy of Military Sciences, Tianjin 300050, China. 2. School of Public Health, Weifang Medical University, Weifang 261053

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Glutamate is the main excitatory neurotransmitter in the central nervous system. Under physiological conditions, glutamate plays an important role in signal transduction. Under pathological conditions, abnormal accumulation of extracellular glutamate can easily cause a series of excitotoxic injuries such as cytoxic edema, degeneration and death of neurons, leading to various nervous system diseases such as Parkinson’ s disease, Alzheimer’ s disease, epilepsy, retinal damage, and hearing loss. Glutamate-aspartate transporter (GLAST) is one of the main excitatory glutamate transporters that maintains the concentration of glutamate at the optimal extracellular level, which prevents glutamate from accumulating in the synaptic space to produce excitotoxicity. This review clarifies the research progress of GLAST in nervous system diseases to understand GLAST-related mechanisms.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 16,2022
  • Revised:
  • Adopted:
  • Online: March 16,2023
  • Published: